汇宇制药(688553.SH)拟出资1.5亿元参与设立私募基金

Core Viewpoint - The company, Huyou Pharmaceutical (688553.SH), announced plans to jointly invest in a private equity fund focused on the biomedical sector, particularly targeting clinical-stage projects with clear commercial potential [1] Investment Details - The company will collaborate with Xiaochi Capital and Chengdu Guanghua Wutong Equity Investment Fund Management Co., Ltd., among other partners, to establish the Chengdu Huyou Xiaochi Biomedical Venture Capital Partnership (Limited Partnership) [1] - The initial subscription scale of the private equity fund is set at 400 million yuan, with the company committing 150 million yuan, representing 37.50% of the total initial subscription amount [1]